Total Payments
$6,623
2024 Payments
$200.55
Companies
23
Transactions
214
Medicare Patients
10,284
Medicare Billing
$952,099
Payment Breakdown by Category
Food & Beverage$3,305 (49.9%)
Research$2,006 (30.3%)
Travel$1,192 (18.0%)
Education$119.98 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,305 | 206 | 49.9% |
| Unspecified | $2,006 | 3 | 30.3% |
| Travel and Lodging | $1,192 | 2 | 18.0% |
| Education | $119.98 | 3 | 1.8% |
Payments by Type
General
$4,617
211 transactions
Research
$2,006
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Research Incorporated | $2,006 | 3 | $0 (2020) |
| Medtronic Vascular, Inc. | $1,535 | 15 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $603.44 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $556.31 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $491.27 | 27 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $396.69 | 22 | $0 (2021) |
| PFIZER INC. | $201.70 | 13 | $0 (2021) |
| ARALEZ PHARMACEUTICALS US INC. | $138.30 | 10 | $0 (2018) |
| Boston Scientific Corporation | $110.66 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $103.22 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.55 | 9 | Boston Scientific Corporation ($59.95) |
| 2023 | $88.30 | 5 | Novartis Pharmaceuticals Corporation ($36.17) |
| 2022 | $72.56 | 4 | CARDIVA MEDICAL, INC. ($41.69) |
| 2021 | $576.25 | 39 | Novartis Pharmaceuticals Corporation ($182.70) |
| 2020 | $2,415 | 27 | Cook Research Incorporated ($2,006) |
| 2019 | $616.16 | 36 | Janssen Pharmaceuticals, Inc ($237.08) |
| 2018 | $1,776 | 45 | Medtronic Vascular, Inc. ($1,295) |
| 2017 | $878.81 | 49 | Medtronic Vascular, Inc. ($239.86) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | CORDIS US CORP. | MYNX CONTROL (Device) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular | ||||||
| 06/25/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: AVVIGO_IC | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Boston Scientific Corporation | OptiCross (Device) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: OptiCross_IC | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: Cardiovascular | ||||||
| 03/07/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $40.73 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Cardiovascular | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: Cardiovascular | ||||||
| 11/09/2023 | Boston Scientific Corporation | OptiCross (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: OptiCross_IC | ||||||
| 06/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: Cardiovascular | ||||||
| 02/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/01/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2022 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: DEVICES | ||||||
| 04/06/2022 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: DEVICES | ||||||
| 07/27/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/14/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/16/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Cardiovascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| (12-004) Zilver PTX V Post Market Study in the US | Cook Research Incorporated | $2,006 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 2,679 | 3,531 | $2.5M | $244,965 |
| 2022 | 34 | 2,012 | 2,517 | $1.8M | $183,405 |
| 2021 | 42 | 2,742 | 3,677 | $1.3M | $264,244 |
| 2020 | 43 | 2,851 | 3,741 | $1.3M | $259,487 |
Total Patients
10,284
Total Services
13,466
Medicare Billing
$952,099
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 467 | 812 | $210,308 | $68,530 | 32.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 67 | 80 | $403,760 | $31,853 | 7.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 110 | 113 | $500,477 | $19,630 | 3.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 113 | 200 | $70,000 | $17,511 | 25.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 135 | 138 | $336,410 | $12,243 | 3.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 184 | $42,320 | $10,912 | 25.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 45 | 46 | $54,533 | $8,571 | 15.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 61 | $25,925 | $5,887 | 22.7% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 29 | 29 | $144,913 | $5,512 | 3.8% |
| 92937 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary vessel with distal protection | Facility | 2023 | 12 | 13 | $65,611 | $5,285 | 8.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $105,716 | $4,785 | 4.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $15,566 | $4,622 | 29.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 55 | 57 | $66,240 | $4,540 | 6.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 78 | 78 | $92,820 | $4,089 | 4.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 22 | 43 | $15,609 | $3,804 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 292 | 347 | $51,356 | $3,488 | 6.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 19 | 76 | $18,468 | $3,079 | 16.7% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 44 | 44 | $36,256 | $3,063 | 8.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $12,480 | $2,926 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $6,613 | $1,969 | 29.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 194 | 206 | $40,788 | $1,946 | 4.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 22 | $6,402 | $1,880 | 29.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 16 | 16 | $20,199 | $1,598 | 7.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 31 | 68 | $10,744 | $1,568 | 14.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 42 | 93 | $12,555 | $1,510 | 12.0% |
About Dr. Bashir Lone, MD
Dr. Bashir Lone, MD is a Cardiovascular Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205862943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bashir Lone, MD has received a total of $6,623 in payments from pharmaceutical and medical device companies, with $200.55 received in 2024. These payments were reported across 214 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,305).
As a Medicare-enrolled provider, Lone has provided services to 10,284 Medicare beneficiaries, totaling 13,466 services with total Medicare billing of $952,099. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Columbia, SC
- Active Since 06/24/2006
- Last Updated 08/24/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205862943
Products in Payments
- Cook Medical Self-Expanding Stent (Device) $2,006
- SpiderFX (Device) $1,192
- ELIQUIS (Drug) $790.69
- ENTRESTO (Drug) $472.07
- BRILINTA (Drug) $443.85
- XARELTO (Drug) $396.69
- Reveal LINQ (Device) $149.80
- ZONTIVITY (Drug) $138.30
- VERQUVO (Drug) $103.22
- LEQVIO (Drug) $84.24
- MitraClip System (Device) $71.16
- LifeVest (Device) $69.17
- VenaSeal (Device) $67.11
- EverFlex (Device) $66.49
- Repatha (Biological) $65.17
- OptiCross (Device) $50.59
- Assure WCD (Device) $40.73
- WATCHMAN (Device) $30.97
- AVVIGO Guidance System (Device) $29.10
- ClosureFast (Device) $28.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbia
Dr. Patrick Mccann, M.d, M.D
Cardiovascular Disease — Payments: $687,373
Cardiovascular Disease $687,373
Dr. James Fairlamb, M.d, M.D
Cardiovascular Disease — Payments: $450,127
Cardiovascular Disease $450,127
Taishi Hirai, Md, MD
Cardiovascular Disease — Payments: $164,143
Cardiovascular Disease $164,143
Dr. Sultan Siddique, M.d, M.D
Cardiovascular Disease — Payments: $123,448
Cardiovascular Disease $123,448
Dr. James Ampadu, M.d, M.D
Cardiovascular Disease — Payments: $78,753
Cardiovascular Disease $78,753
Michael Cryer, M.d, M.D
Cardiovascular Disease — Payments: $75,074
Cardiovascular Disease $75,074